SCHEMBL34468859

SCHEMBL34468859

O=C(NC(c1ccccc1)c1ccccc1)c1cc2ccccc2[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 3/20 0.52
▸ HSD17B2 P37059 11/20 0.50
▸ CCR1 P32246 1/20 0.48
▸ EGLN1 Q9GZT9 2/20 0.47
▸ DAO P14920 1/20 0.46
▸ DDO Q99489 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34468797 0.86 KDM4E (0.62) SMYD3CCR1EGLN1
SCHEMBL34468812 0.86 KDM4E (0.62) SMYD3CCR1EGLN1
SCHEMBL34468866 0.86 KDM4E (0.62) SMYD3CCR1EGLN1
SCHEMBL1440740 0.83 SMYD3 (0.57) SMYD3CCR1DAODDO
SCHEMBL34468801 0.80 DRD2 (0.55) SMYD3CCR1DAODDO
SCHEMBL34468764 0.78 SMYD3 (0.56) SMYD3CCR1
SCHEMBL30395353 0.78 NPC1 (0.66) SMYD3DAODDO
SCHEMBL6168742 0.78 NPC1 (0.66) SMYD3DAODDO
SCHEMBL34468760 0.78 NPC1 (0.54) SMYD3CCR1
SCHEMBL34468770 0.78 CCR1 (0.62) SMYD3CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090571-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. (US) 2026-04-30 — — WO claimed
US-20260116873-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2026-04-30 — — US claimed
WO-2026090571-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. (US) 2026-04-30 — — WO disclosed
US-20260116873-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2026-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116873-A1 APYRASE INHIBITORS APEH, AP3M1, SRR SMYD3 1625/4885HSD17B2 1693/4885CCR1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback